A Pharmacokinetic Study to Compare Sustained Release and Standard Paracetamol Formulations.
NCT01551797
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
14
Enrollment
INDUSTRY
Sponsor class
Conditions
Pain
Interventions
DRUG:
Paracetamol 500 mg
DRUG:
Paracetamol 1000 mg
DRUG:
Paracetamol 750 mg
Sponsor
GlaxoSmithKline